Publications for Mikael Hoffmann
Co-author map based on ISI articles 2007-

Publications mentioned in social media 10 times*

Keywords

women treatment tillstånd therapy sällsynta symptoms swedish svåra risk patients menopause läkemedel landsting ht hormone discussion consultations benefit behandling antibiotic

Journal Articles

Martin Holmbom, Christian G. Giske, Mats Fredrikson, Åse Östholm Balkhed, Carina Claesson, Lennart E Nilsson, Mikael Hoffmann and Håkan Hanberger
  14-Year Survey in a Swedish County Reveals a Pronounced Increase in Bloodstream Infections (BSI). Comorbidity: An Independent Risk Factor for Both BSI and Mortality
 
Altmetric usage: 2

  PLoS ONE, 2016, 11(11), .
   Fulltext  PDF  

Susanna M. Wallerstedt, Björn Wettermark and Mikael Hoffmann
  The First Decade with the Swedish Prescribed Drug Register - A Systematic Review of the Output in the Scientific Literature
 
Altmetric usage: 2

  Basic & Clinical Pharmacology & Toxicology, 2016, 119(5), 464-469.
   Fulltext  PDF  

Lotta Lindh-Åstrand, Mikael Hoffmann, Lotta Järvstråt, Mats Fredrikson, Mats Hammar and Anna-Clara Spetz
  Hormone therapy might be underutilized in women with early menopause.
  Human Reproduction, 2015, 30(4), 848-852.
 Web of Science® Times Cited: 3

Lotta Järvstråt, Anna-Clara Spetz, Lotta Lindh-Åstrand, Mikael Hoffmann, Mats Fredrikson and Mats Hammar
  Use of hormone therapy in Swedish women aged 80 years or older
 
Altmetric usage: 1

  Menopause: The Journal of the North American Menopause, 2015, 22(3), 275-278.
   Fulltext  PDF  
 Web of Science® Times Cited: 3

Lotta Lindh-Åstrand, Mikael Hoffmann, Mats Hammar and Anna-Clara Spetz
  Hot flushes, hormone therapy and alternative treatments: 30 years of experience from Sweden
 
Altmetric usage: 2

  Climacteric, 2015, 18(1), 53-62.
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Inger Hallberg, Charles Taft, Agneta Ranerup, Ulrika Bengtsson, Mikael Hoffman, Stefan Höfer, Dick Kasperowski, Åsa Mäkitalo, Mona Lundin, Lena Ring, Ulf Rosenqvist and Karin I Kjellgren
  Phases in development of an interactive mobile phone-based system to support self-management of hypertension
 
Altmetric usage: 1

  Integrated Blood Pressure Control, 2014, 7, 19-28.
   Fulltext  PDF  

Lotta Lindh-Åstrand, Jan Brynhildsen, Mikael Hoffman and Mats Hammar
  Vasomotor symptoms usually reappear after cessation of postmenopausal hormone therapy: a Swedish population-based study.
 
Altmetric usage: 2

  Menopause (New York, N.Y.), 2009, , .
   Fulltext  PDF  
 Web of Science® Times Cited: 12

B. Godman, B. Wettermark, M. Hoffmann, K. Andersson, A. Haycox and L.L. Gustafsson
  Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: Global relevance
  Expert Review of Pharmacoeconomics and Outcomes Research, 2009, 9(1), 65-83.

Lotta Lindh-Åstrand, Jan Brynhildsen, Mikael Hoffmann, Karin I Kjellgren and Mats Hammar
  Knowledge of reproductive physiology and hormone therapy in 53- to 54-year-old Swedish women: a population-based study.
  Menopause, 2007, 14(6), 1039-1046.
   Fulltext  PDF  
 Web of Science® Times Cited: 5

Lotta Lindh-Åstrand, Jan Brynhildsen, Mikael Hoffmann, Susanne Liffner and Mats Hammar
  Attitudes towards the menopause and hormone therapy over the turn of the century
  Maturitas, 2007, 56(1), 12-20.
   Fulltext  PDF  
 Web of Science® Times Cited: 13

Lotta Lindh-Åstrand, Mikael Hoffmann, Mats Hammar and Karin I. Kjellgren
  Women’s conception of the menopausal transition – a qualitative study
  Journal of Clinical Nursing, 2007, 16(3), 509-517.
   Fulltext  PDF  
 Web of Science® Times Cited: 13

Mikael Hoffmann, Mats Hammar, Lotta Lindh-Åstrand and Johan Ahlner
  Risk communication in consultations about hormone therapy in the menopause – concordance in risk assessment and framing due to the context
  Climacteric, 2006, 9(5), 347-354.
   Fulltext  PDF  
 Web of Science® Times Cited: 5

Mikael Hoffmann, Mats Hammar, Karin Kjellgren, Lotta Lindh-Åstrand and Johan Ahlner
  Risk communication in consultations about hormone therapy in the menopause: concordance in risk assessment and framing due to the context
  Climacteric, 2006, 9(5), 347-354.
 Web of Science® Times Cited: 5

Mikael Hoffmann, Mats Hammar, Karin I. Kjellgren, Lotta Lindh-Åstrand and Jan Brynhildsen
  Changes in women’s attitudes towards and use of hormone therapy after HERS and WHI
  Maturitas, 2005, 52(1), 11-17.
 Web of Science® Times Cited: 47

Mikael Hoffmann, Lotta Lindh-Åstrand, Johan Ahlner, Mats Hammar and Karin I. Kjellgren
  Hormone replacement therapy in the menopause - structure and content of risk talk
  Maturitas, 2005, 50(1), 8-18.
 Web of Science® Times Cited: 12

Mikael Hoffmann, Per Linell, Lotta Lindh-Åstrand and Karin I. Kjellgren
  Risk talk: rhetorical strategies in consultations on hormone replacement therap
  Health, Risk and Society, 2005, 5(2), 139-154.
 Web of Science® Times Cited: 8

Sten Walther, M. Erlandsson, B. Olsson-Liljequist, Håkan Hanberger, The Icustrama Study Group (2002), L.G. Burman, O. Cars, Hans Gill, Mikael Hoffman, Barbro Isaksson, G. Kahlmeter, S. Lindgren and Lennart Nilsson
  Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units
  Acta Anaesthesiologica Scandinavica, 2002, 46(9), 1075-1081.
 Web of Science® Times Cited: 27

L Molander, A Hansson, E Lunell, L Alainentalo, Mikael Hoffman and Rutger Larsson
  Pharmacokinetics of nicotine in kidney failure
  Clinical Pharmacology and Therapeutics, 2000, 68(3), 250-260.
 Web of Science® Times Cited: 25

Marcus Erlandsson, Håkan Hanberger, Mikael Hoffmann, Barbro Isaksson, Sune Lindgren, L. Sörén and Sten Walther
  Surveillance of Antibiotic Resistance in ICUs in Southeastern Sweden
  Acta Anaesthesiol Scand, 1999, 43(8), 815-820.

Chapters in Books

Per Carlsson, Mikael Hoffman, Lars-Åke Levin, Lars Sandman and Johanna Wiss
  Prioritering av läkemedel för behandling av patienter med sällsynta sjukdomar
  Läkemedel för djur, maskinell dos och sällsynta tillstånd: hantering och prissättning. Slutbetänkande av Läkemedels- och apoteksutredningen, Fritzes, 2014, 639-699.


  Fulltext PDF

Conference Articles

Karin Wårdell, Mikael Hoffman, Michail Ilias, Göran Salerud and M. Stücker
  Karaktärisering av blodperfusionen I hudlesioner med laser Doppler perfusion imaging
  Svenska Läkarsällskapets Riksstämma,2000, 2000.


Ph.D. Theses

Mikael Hoffmann
  Risk Talk: On Communicating Benefits and Harms in Health Care
  2006.


  Fulltext PDF

Reports

Per Carlsson, Mikael Hoffmann, Lars-Åke Levin, Lars Sandman and Johanna Wiss
  Prioritering och finansiering av läkemedel för behandling av patienter med sällsynta sjukdomar: Reviderad version
  Rapport / Prioriteringscentrum, 2015:1, 2015.


  Fulltext PDF

Per Carlsson, Mikael Hoffmann, Lars-Åke Levin, Lars Sandman and Johanna Wiss
  Prioritering och finansiering av läkemedel för behandling av patienter med sällsynta sjukdomar
  Rapport / Prioriteringscentrum, 2012:1, 2012.


  Fulltext PDF

Lars-Åke Levin, David Andersson, Anders Anell, Emelie Heintz, Mikael Hoffman, Andrea Schmidt and Per Carlsson
  Styrformer för effektiv läkemedelsanvändning
  CMT Rapport, 2010:2, 2010.


  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.